Mitali Patel
University College London
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mitali Patel.
Human Molecular Genetics | 2014
Alexandros Onoufriadis; Amelia Shoemark; Miriam Schmidts; Mitali Patel; Gina Jimenez; Hui Liu; Biju Thomas; Mellisa Dixon; Robert A. Hirst; Andrew Rutman; Thomas Burgoyne; Christopher Williams; Juliet Scully; Florence Bolard; Jean-Jacques Lafitte; Philip L. Beales; Claire Hogg; Pinfen Yang; Eddie M. K. Chung; Richard D. Emes; Christopher O'Callaghan; Uk K; Patrice Bouvagnet; Hannah M. Mitchison
Primary ciliary dyskinesia (PCD) is an inherited chronic respiratory obstructive disease with randomized body laterality and infertility, resulting from cilia and sperm dysmotility. PCD is characterized by clinical variability and extensive genetic heterogeneity, associated with different cilia ultrastructural defects and mutations identified in >20 genes. Next generation sequencing (NGS) technologies therefore present a promising approach for genetic diagnosis which is not yet in routine use. We developed a targeted panel-based NGS pipeline to identify mutations by sequencing of selected candidate genes in 70 genetically undefined PCD patients. This detected loss-of-function RSPH1 mutations in four individuals with isolated central pair (CP) agenesis and normal body laterality, from two unrelated families. Ultrastructural analysis in RSPH1-mutated cilia revealed transposition of peripheral outer microtubules into the ‘empty’ CP space, accompanied by a distinctive intermittent loss of the central pair microtubules. We find that mutations in RSPH1, RSPH4A and RSPH9, which all encode homologs of components of the ‘head’ structure of ciliary radial spoke complexes identified in Chlamydomonas, cause clinical phenotypes that appear to be indistinguishable except at the gene level. By high-resolution immunofluorescence we identified a loss of RSPH4A and RSPH9 along with RSPH1 from RSPH1-mutated cilia, suggesting RSPH1 mutations may result in loss of the entire spoke head structure. CP loss is seen in up to 28% of PCD cases, in whom laterality determination specified by CP-less embryonic node cilia remains undisturbed. We propose this defect could arise from instability or agenesis of the ciliary central microtubules due to loss of their normal radial spoke head tethering.
Journal of Medical Genetics | 2014
Alexandros Onoufriadis; Amelia Shoemark; Mustafa M. Munye; Chela James; Miriam Schmidts; Mitali Patel; Elisabeth Rosser; Chiara Bacchelli; Philip L. Beales; Peter J. Scambler; Stephen L. Hart; Jeannette E Danke-Roelse; John J Sloper; Sarah Hull; Claire Hogg; Richard D. Emes; Gerard Pals; Anthony T. Moore; Eddie M. K. Chung; Hannah M. Mitchison
Background Primary ciliary dyskinesia (PCD) is a rare, genetically heterogeneous ciliopathy disorder affecting cilia and sperm motility. A range of ultrastructural defects of the axoneme underlie the disease, which is characterised by chronic respiratory symptoms and obstructive lung disease, infertility and body axis laterality defects. We applied a next-generation sequencing approach to identify the gene responsible for this phenotype in two consanguineous families. Methods and results Data from whole-exome sequencing in a consanguineous Turkish family, and whole-genome sequencing in the obligate carrier parents of a consanguineous Pakistani family was combined to identify homozygous loss-of-function mutations in ARMC4, segregating in all five affected individuals from both families. Both families carried nonsense mutations within the highly conserved armadillo repeat region of ARMC4: c.2675C>A; pSer892* and c.1972G>T; p.Glu658*. A deficiency of ARMC4 protein was seen in patients respiratory cilia accompanied by loss of the distal outer dynein arm motors responsible for generating ciliary beating, giving rise to cilia immotility. ARMC4 gene expression is upregulated during ciliogenesis, and we found a predicted interaction with the outer dynein arm protein DNAI2, mutations in which also cause PCD. Conclusions We report the first use of whole-genome sequencing to identify gene mutations causing PCD. Loss-of-function mutations in ARMC4 cause PCD with situs inversus and cilia immotility, associated with a loss of the distal outer (but not inner) dynein arms. This addition of ARMC4 to the list of genes associated with ciliary outer dynein arm defects expands our understanding of the complexities of PCD genetics.
Nature Communications | 2017
Chiara Olcese; Mitali Patel; Amelia Shoemark; Santeri Kiviluoto; Marie Legendre; Hywel Williams; Cara K. Vaughan; Jane Hayward; Alice Goldenberg; Richard D. Emes; Mustafa M. Munye; Laura Dyer; Thomas Joseph Cahill; Jeremy Bevillard; Corinne Gehrig; Michel Guipponi; Sandra Chantot; Philippe Duquesnoy; Lucie Thomas; Ludovic Jeanson; Bruno Copin; Aline Tamalet; Christel Thauvin-Robinet; Jean Francois Papon; Antoine Garin; Isabelle Pin; Gabriella Vera; Paul Aurora; Mahmoud R. Fassad; Lucy Jenkins
By moving essential body fluids and molecules, motile cilia and flagella govern respiratory mucociliary clearance, laterality determination and the transport of gametes and cerebrospinal fluid. Primary ciliary dyskinesia (PCD) is an autosomal recessive disorder frequently caused by non-assembly of dynein arm motors into cilia and flagella axonemes. Before their import into cilia and flagella, multi-subunit axonemal dynein arms are thought to be stabilized and pre-assembled in the cytoplasm through a DNAAF2–DNAAF4–HSP90 complex akin to the HSP90 co-chaperone R2TP complex. Here, we demonstrate that large genomic deletions as well as point mutations involving PIH1D3 are responsible for an X-linked form of PCD causing disruption of early axonemal dynein assembly. We propose that PIH1D3, a protein that emerges as a new player of the cytoplasmic pre-assembly pathway, is part of a complementary conserved R2TP-like HSP90 co-chaperone complex, the loss of which affects assembly of a subset of inner arm dyneins.
American Journal of Respiratory and Critical Care Medicine | 2017
Amelia Shoemark; Emily Frost; Mellisa Dixon; Sarah Ollosson; Kate Kilpin; Mitali Patel; Juliet Scully; Andrew V. Rogers; Hannah M. Mitchison; Andrew Bush; Claire Hogg
Rationale: The standard approach to diagnosis of primary ciliary dyskinesia (PCD) in the United Kingdom consists of assessing ciliary function by high‐speed microscopy and ultrastructure by election microscopy, but equipment and expertise is not widely available internationally. The identification of biallelic disease‐causing mutations is also diagnostic, but many disease‐causing genes are unknown, and testing is not widely available outside the United States. Fluorescent antibodies to ciliary proteins are used to validate research genetic studies, but diagnostic utility in this disease has not been systematically evaluated. Objectives: To determine utility of a panel of six fluorescent labeled antibodies as a diagnostic tool for PCD. Methods: The study used immunofluorescent labeling of nasal brushings from a discovery cohort of 35 patients diagnosed with PCD by ciliary ultrastructure, and a diagnostic accuracy cohort of 386 patients referred with symptoms suggestive of disease. The results were compared with diagnostic outcome. Measurements and Main Results: Immunofluorescence correctly identified mislocalized or absent staining in 100% of the discovery cohort. In the diagnostic cohort immunofluorescence successfully identified 22 of 25 patients with PCD and normal staining in all 252 in whom PCD was considered highly unlikely. In addition, immunofluorescence provided a result in 55% (39) of cases that were previously inconclusive. Immunofluorescence results were available within 14 days, costing
Thorax | 2017
Amelia Shoemark; Eduardo Moya; Robert A. Hirst; Mitali Patel; Evelyn Robson; Jane Hayward; Miriam Schmidts; C. Hogg; Hannah M. Mitchison
187 per sample compared with electron microscopy (27 days; cost
Lung | 2018
S. Irving; Mellisa Dixon; Mahmoud R. Fassad; E. Frost; Jane Hayward; K. Kilpin; Sarah Ollosson; Alexandros Onoufriadis; Mitali Patel; Juliet Scully; Siobhán B. Carr; Hannah M. Mitchison; Michael R. Loebinger; Claire Hogg; Amelia Shoemark; Andrew Bush
1,452). Conclusions: Immunofluorescence is a highly specific diagnostic test for PCD, and it improves the speed and availability of diagnostic testing. However, sensitivity is limited and immunofluorescence is not suitable as a stand‐alone test.
Human Molecular Genetics | 2018
Verity L Hartill; Glenn van de Hoek; Mitali Patel; Rosie Little; Christopher M Watson; Ian R. Berry; Amelia Shoemark; Dina I. Abdelmottaleb; Emma Parkes; Chiara Bacchelli; Katarzyna Szymanska; N.V.A.M. Knoers; Peter J. Scambler; Marius Ueffing; Karsten Boldt; Robert Yates; Paul J.D. Winyard; Beryl Adler; Eduardo Moya; Louise Hattingh; Anil Shenoy; Claire Hogg; Eamonn Sheridan; Ronald Roepman; Dominic P. Norris; Hannah M. Mitchison; Rachel H. Giles; Colin A. Johnson
Rationale Primary ciliary dyskinesia is a genetically heterogeneous inherited condition characterised by progressive lung disease arising from abnormal cilia function. Approximately half of patients have situs inversus. The estimated prevalence of primary ciliary dyskinesia in the UK South Asian population is 1:2265. Early, accurate diagnosis is key to implementing appropriate management but clinical diagnostic tests can be equivocal. Objectives To determine the importance of genetic screening for primary ciliary dyskinesia in a UK South Asian population with a typical clinical phenotype, where standard testing is inconclusive. Methods Next-generation sequencing was used to screen 86 South Asian patients who had a clinical history consistent with primary ciliary dyskinesia. The effect of a CCDC103 p.His154Pro missense variant compared with other dynein arm-associated gene mutations on diagnostic/phenotypic variability was tested. CCDC103 p.His154Pro variant pathogenicity was assessed by oligomerisation assay. Results Sixteen of 86 (19%) patients carried a homozygous CCDC103 p.His154Pro mutation which was found to disrupt protein oligomerisation. Variable diagnostic test results were obtained including normal nasal nitric oxide levels, normal ciliary beat pattern and frequency and a spectrum of partial and normal dynein arm retention. Fifteen (94%) patients or their sibling(s) had situs inversus suggesting CCDC103 p.His154Pro patients without situs inversus are missed. Conclusions The CCDC103 p.His154Pro mutation is more prevalent than previously thought in the South Asian community and causes primary ciliary dyskinesia that can be difficult to diagnose using pathology-based clinical tests. Genetic testing is critical when there is a strong clinical phenotype with inconclusive standard diagnostic tests.
Cilia | 2015
E Robson; Eduardo Moya; T Burgoyne; P Chetcuti; M Dixon; Robert A. Hirst; C Hogg; Hannah M. Mitchison; Christopher O'Callaghan; Alexandros Onoufriadis; Mitali Patel; Andrew Rutman; Eamonn Sheridan; A Shoemark
PurposePrimary ciliary dyskinesia (PCD) is characterised by repeated upper and lower respiratory tract infections, neutrophilic airway inflammation and obstructive airway disease. Different ultrastructural ciliary defects may affect lung function decline to different degrees. Lung clearance index (LCI) is a marker of ventilation inhomogeneity that is raised in some but not all patients with PCD. We hypothesised that PCD patients with microtubular defects would have worse (higher) LCI than other PCD patients.MethodsSpirometry and LCI were measured in 69 stable patients with PCD. Age at testing, age at diagnosis, ethnicity, ciliary ultrastructure, genetic screening result and any growth of Pseudomonas aeruginosa was recorded.ResultsLung clearance index was more abnormal in PCD patients with microtubular defects (median 10.24) than those with dynein arm defects (median 8.3, p = 0.004) or normal ultrastructure (median 7.63, p = 0.0004). Age is correlated with LCI, with older patients having worse LCI values (p = 0.03, r = 0.3).ConclusionThis study shows that cilia microtubular defects are associated with worse LCI in PCD than dynein arm defects or normal ultrastructure. The patient’s age at testing is also associated with a higher LCI. Patients at greater risk of obstructive lung disease should be considered for more aggressive management. Differences between patient groups may potentially open avenues for novel treatments.
Thorax | 2018
Sunayna Best; Amelia Shoemark; Bruna Rubbo; Mitali Patel; Mahmoud R. Fassad; Mellisa Dixon; Andrew V. Rogers; Robert A. Hirst; Andrew Rutman; Sarah Ollosson; Claire Jackson; Patricia Goggin; Simon H. L. Thomas; Reuben J. Pengelly; Thomas Cullup; Eleni Pissaridou; Jane Hayward; Alexandros Onoufriadis; Christopher O’Callaghan; Michael R. Loebinger; Robert S. Wilson; Eddie M. K. Chung; Priti Kenia; Victoria L Doughty; Julene S Carvalho; Jane S. Lucas; Hannah M. Mitchison; Claire Hogg
Abstract DNAAF1 (LRRC50) is a cytoplasmic protein required for dynein heavy chain assembly and cilia motility, and DNAAF1 mutations cause primary ciliary dyskinesia (PCD; MIM 613193). We describe four families with DNAAF1 mutations and complex congenital heart disease (CHD). In three families, all affected individuals have typical PCD phenotypes. However, an additional family demonstrates isolated CHD (heterotaxy) in two affected siblings, but no clinical evidence of PCD. We identified a homozygous DNAAF1 missense mutation, p.Leu191Phe, as causative for heterotaxy in this family. Genetic complementation in dnaaf1-null zebrafish embryos demonstrated the rescue of normal heart looping with wild-type human DNAAF1, but not the p.Leu191Phe variant, supporting the conserved pathogenicity of this DNAAF1 missense mutation. This observation points to a phenotypic continuum between CHD and PCD, providing new insights into the pathogenesis of isolated CHD. In further investigations of the function of DNAAF1 in dynein arm assembly, we identified interactions with members of a putative dynein arm assembly complex. These include the ciliary intraflagellar transport protein IFT88 and the AAA+ (ATPases Associated with various cellular Activities) family proteins RUVBL1 (Pontin) and RUVBL2 (Reptin). Co-localization studies support these findings, with the loss of RUVBL1 perturbing the co-localization of DNAAF1 with IFT88. We show that RUVBL1 orthologues have an asymmetric left-sided distribution at both the mouse embryonic node and the Kupffer’s vesicle in zebrafish embryos, with the latter asymmetry dependent on DNAAF1. These results suggest that DNAAF1-RUVBL1 biochemical and genetic interactions have a novel functional role in symmetry breaking and cardiac development.
European Respiratory Journal | 2018
Amelia Shoemark; Thomas Burgoyne; Robert Kwan; Mellisa Dixon; Mitali Patel; Andrew V. Rogers; Alexandros Onoufriadis; Juliet Scully; Farheen Daudvohra; Thomas Cullup; Michael R. Loebinger; Robert S. Wilson; Eddie M. K. Chung; Andrew Bush; Hannah M. Mitchison; Claire Hogg
Objectives PCD is an autosomal recessive condition that affects the structure and function of motile cilia in the respiratory tract, middle ear and reproductive organs. The estimated prevalence is 1:15,000, but as high as 1:2265 in the British Asian population. Mutations in the CCDC103 gene have recently been identified as PCD disease-causing in Pakistani individuals. It is found to be an essential gene for dynein arm assembly and ciliary motility.